Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Situation Critical: Drug Companies Failing to Meet Journalists’ Needs

By ISEBOX | June 20, 2017

New research reveals a huge gulf between the information provided by drug companies and what journalists actually need to create their content.

The survey, conducted by digital communications platform ISEBOX, reveals that 85 percent of health journalists view healthcare communications as either “out of shape” or “on life support.”

Half (50 percent) admit they never visit the newsrooms of drug companies, with almost a quarter (22 percent) calling them “unsatisfactory” and two thirds (64 percent) saying there is “room for improvement” when it comes to the information provided.

The survey questioned more than 166 health journalists across the UK and US to assess what information provided by pharmaceutical and healthcare companies is of most value to them and their audiences.

It reveals that when it comes to providing relevant content for journalists, pharmaceutical and healthcare companies are off the mark.

In fact, just 15 percent of journalists rated healthcare communications as “healthy and fit” with almost three quarters of those questioned (71 percent) declaring the relationship “out of shape” and 14 percent feeling that it is “on life support.”

Part of the problem is about trust—with the survey revealing that only 2 percent of journalists find the information and press releases provided by pharmaceutical and healthcare companies “trustworthy.”

While 16 percent say they do not trust this information at all, almost half (48 percent) only somewhat trust it.

However, 36 percent of journalists said that the FDA/EMA restrictions on communicating industry news are in the best interests of the consumer, with almost half (44 percent) saying they are sometimes in their best interests.

Health journalist and media communications consultant Jo Willey, director of Jo Willey Media, said: “This research shows that there is still a long way to go when it comes to breathing new life into healthcare communications.

“Regulations are welcome and necessary. However, care must be taken that these regulations—or the fear of breaching them—do not prevent pharmaceutical companies from effectively communicating accurate, creative content.

“Journalists still need newsworthy, simple, clear content relevant to their outlet, whether that is traditional print media, web, radio, TV or social media. Over-complication or irrelevant content opens up the possibility of miscommunication, something which could be far more damaging.”

The survey also found that when it comes to the most useful video content, journalists overwhelmingly want independent medical expert testimonial (48 percent) as well as patient testimonials (14 percent) and B-roll (11 percent).

Only 22 percent of those questioned said pharma and healthcare news and launches provide enough relevant visual content.

Marc de Leuw, chief executive officer of ISEBOX, said: “Healthcare communications is clearly a balancing act between the governance placed on drug companies and a press eager for transparency and meaningful content. It’s in the interest of both parties to enter a more open dialogue to raise the bar on effective information exchange.”

(Source: PR Newswire, ISEBOX)

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE